Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A dose-intensive approach (NB96) for induction therapy utilizing sequential high-dose chemotherapy and stem cell rescue in high-risk neuroblastoma in children over 1 year of age.
Monnereau-Laborde S, Munzer C, Valteau-Couanet D, Ansoborlo S, Coze C, Chastagner P, Rubie H, Demeocq F, Stephan JL, Hartmann O, Perel Y. Monnereau-Laborde S, et al. Among authors: munzer c. Pediatr Blood Cancer. 2011 Dec 1;57(6):965-71. doi: 10.1002/pbc.23232. Epub 2011 Jul 8. Pediatr Blood Cancer. 2011. PMID: 21744481 Clinical Trial.
Prospective validation of an equation based on plasma cystatin C for monitoring the glomerular filtration rate in children treated with cisplatin or ifosfamide for cancer.
Lambert M, Alonso M, Munzer C, Zimoch MC, Malard L, Gambart M, Castex MP, Martins C, Pasquet M, Chatelut E. Lambert M, et al. Among authors: munzer c. Cancer Chemother Pharmacol. 2024 Apr;93(4):393-395. doi: 10.1007/s00280-023-04597-6. Epub 2023 Oct 3. Cancer Chemother Pharmacol. 2024. PMID: 37789166
Neuroblastoma in adolescents.
Gaspar N, Hartmann O, Munzer C, Bergeron C, Millot F, Cousin-Lafay L, Babin-Boilletot A, Blouin P, Pajot C, Coze C. Gaspar N, et al. Among authors: munzer c. Cancer. 2003 Jul 15;98(2):349-55. doi: 10.1002/cncr.11521. Cancer. 2003. PMID: 12872356 Free article.
Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy.
Rubie H, Coze C, Plantaz D, Munzer C, Defachelles AS, Bergeron C, Thomas C, Chastagner P, Valteau-Couanet D, Michon J, Mosseri V, Hartmann O; Neuroblastoma Study Group, Société Française d'Oncologie Pédiatrique. Rubie H, et al. Among authors: munzer c. Br J Cancer. 2003 Nov 3;89(9):1605-9. doi: 10.1038/sj.bjc.6601259. Br J Cancer. 2003. PMID: 14583756 Free PMC article.
Localized cervical neuroblastoma: prevention of surgical complications.
Haddad M, Triglia JM, Helardot P, Couanet D, Gauthier F, Neuenschwander S, Bourlière B, Bergeron C, Munzer C, Rubie H, Guys JM; French Society of Pediatric Oncology. Haddad M, et al. Among authors: munzer c. Int J Pediatr Otorhinolaryngol. 2003 Dec;67(12):1361-7. doi: 10.1016/j.ijporl.2003.08.046. Int J Pediatr Otorhinolaryngol. 2003. PMID: 14643482
[Neonatal localized neuroblastoma: 52 cases treated from 1990 to 1999].
Michalowski MB, Rubie H, Michon J, Montamat S, Bergeron C, Coze C, Perel Y, Valteau-Couanet D, Guitard J, Guys JM, Piolat C, Munzer C, Plantaz D; Groupe Neuroblastome de la Société Française d'Oncologie Pédiatrique. Michalowski MB, et al. Among authors: munzer c. Arch Pediatr. 2004 Jul;11(7):782-8. doi: 10.1016/j.arcped.2004.01.020. Arch Pediatr. 2004. PMID: 15234372 French.
High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification.
Laprie A, Michon J, Hartmann O, Munzer C, Leclair MD, Coze C, Valteau-Couanet D, Plantaz D, Carrie C, Habrand JL, Bergeron C, Chastagner P, Défachelles AS, Delattre O, Combaret V, Bénard J, Pérel Y, Gandemer V, Rubie H; Neuroblastoma Study Group of the French Society of Pediatric Oncology. Laprie A, et al. Among authors: munzer c. Cancer. 2004 Sep 1;101(5):1081-9. doi: 10.1002/cncr.20453. Cancer. 2004. PMID: 15329919 Free article.
Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Société Française des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group Study.
Rubie H, Chisholm J, Defachelles AS, Morland B, Munzer C, Valteau-Couanet D, Mosseri V, Bergeron C, Weston C, Coze C, Auvrignon A, Djafari L, Hobson R, Baunin C, Dickinson F, Brisse H, McHugh K, Biassoni L, Giammarile F, Vassal G; Société Françaisedes Cancers de l'Enfant; United Kingdom Children Cancer Study Group-New Agents Group Study. Rubie H, et al. Among authors: munzer c. J Clin Oncol. 2006 Nov 20;24(33):5259-64. doi: 10.1200/JCO.2006.06.1572. J Clin Oncol. 2006. PMID: 17114659 Clinical Trial.
Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification.
Schleiermacher G, Michon J, Huon I, d'Enghien CD, Klijanienko J, Brisse H, Ribeiro A, Mosseri V, Rubie H, Munzer C, Thomas C, Valteau-Couanet D, Auvrignon A, Plantaz D, Delattre O, Couturier J; Société Française des Cancers de l'Enfant (SFCE). Schleiermacher G, et al. Among authors: munzer c. Br J Cancer. 2007 Jul 16;97(2):238-46. doi: 10.1038/sj.bjc.6603820. Epub 2007 Jun 19. Br J Cancer. 2007. PMID: 17579628 Free PMC article.
30 results